Physician profile
Grant William Mathison
NPI 1629482708
$8,738.47
in general payments reported to CMS, 2019-2025
12 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,093 · 2020: $590 · 2021: $4,857 · 2023: $30.77 · 2024: $22.07 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,047.00 | 2021 | |
| Gemini Medical LLC | $2,232.84 | 2020-2021 | |
| Axogen | $1,864.28 | 2019-2021 | |
| Medwest Associates | $533.10 | 2019 | |
| Medical Device Business Services, INC. | $303.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $259.24 | 2019-2024 | Tapestry, Activbraid |
| Foundation Medical, LLC | $145.32 | 2025 | |
| Integra Lifesciences Corporation | $120.20 | 2019 | |
| Medtronic USA, INC. | $84.12 | 2019 | |
| Depuy Synthes Sales INC. | $62.09 | 2019 | |
| Skeletal Dynamics INC | $52.32 | 2019-2023 | Ijs, Geminus, Implate |
| Smith+Nephew, INC. | $34.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Mathison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.